News | April 12, 2024
Generics gain ground, yet HCPs still favor branded drugs, finds GlobalData
A significant proportion of healthcare professionals still tend to favor branded drugs
A significant proportion of healthcare professionals still tend to favor branded drugs
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy
These approvals mark significant progress for Venus Remedies in expanding its market presence
Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully
Aarti Drugs has reported total income of Rs. 607.61 crores during the period ended December 31, 2023
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
Lack of technology transfer stands out as a formidable barrier
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Aarti Drugs has reported total income of Rs. 642.22 crores during the period ended September 30, 2023
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
